Quick Answer
ADMA BIOLOGICS, INC. reported Research And Development Expense of $4.76 million for the year ending 2025.
- ADMA BIOLOGICS, INC. showed an increase of +162.7% in Research And Development Expense from 2024 to 2025.
- This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $56.6 thousand | Q1 2012: $81.8 thousand | Q2 2012: $178.7 thousand | Q3 2012: $1.94 million | Q1 2013: $1.47 million | Q2 2013: $3.47 million | Q3 2013: $1.41 million | Q1 2014: $4.33 million | Q2 2014: $1.78 million | Q3 2014: $1.48 million | Q1 2015: $1.40 million | Q2 2015: $1.51 million | Q3 2015: $2.11 million | Q1 2016: $2.03 million | Q2 2016: $3.40 million | Q3 2016: $1.68 million | Q1 2017: $1.19 million | Q2 2017: $1.36 million | Q3 2017: $1.81 million | Q1 2018: $965.6 thousand | Q2 2018: $1.04 million | Q3 2018: $1.00 million | Q4 2018: $917.3 thousand | Q1 2019: $870.6 thousand | Q1 2019: $300.0 thousand | Q2 2019: $517.0 thousand | Q3 2019: $491.4 thousand | Q1 2020: $1.53 million | Q2 2020: $1.66 million | Q3 2020: $1.71 million | Q1 2021: $987.6 thousand | Q2 2021: $1.16 million | Q3 2021: $770.6 thousand | Q1 2022: $624.1 thousand | Q2 2022: $873.4 thousand | Q3 2022: $1.04 million | Q1 2023: $855.0 thousand | Q2 2023: $1.40 million | Q3 2023: $596.0 thousand | Q1 2024: $450.0 thousand | Q2 2024: $560.0 thousand | Q3 2024: $412.0 thousand | Q1 2025: $826.0 thousand | Q2 2025: $1.03 million | Q3 2025: $1.53 million.
- Over the full 17 years of available data (2011 to 2025), ADMA BIOLOGICS, INC.'s Research And Development Expense has grown by 636.3%.
- Historical annual values: Fiscal year 2025: $4.76 million | Fiscal year 2024: $1.81 million | Fiscal year 2023: $3.30 million | Fiscal year 2022: $3.61 million | Fiscal year 2021: $3.65 million | Fiscal year 2020: $5.91 million | Fiscal year 2019: $2.34 million | Fiscal year 2019: $1.00 million | Fiscal year 2018: $3.93 million | Fiscal year 2017: $5.57 million | Fiscal year 2016: $7.69 million | Fiscal year 2015: $7.02 million | Fiscal year 2014: $9.52 million | Fiscal year 2013: $9.30 million | Fiscal year 2012: $2.00 million | Fiscal year 2012: $3.47 million | Fiscal year 2011: $646.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: